Pfizer is receiving bids on its consumer products unit, with bidders apparently including Glaxo, J&J, and Reckitt Benckiser.
The brands up for sale include Listerine, Sudafed, Rolaids, and Rogaine, and totalled $3.9b in sales and $670 million in profit last yea. This is about 8% of Pfizer's sales and 4% of profit, and the purpose of the sell-off is to concentrate on prescription drugs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment